Radiopharmaceuticals have come a long way in the past decade, however, there are still numerous opportunities in this exciting field to further improve treatment outcomes for cancer patients around the world. Join Clarity’s Executive Chairperson, Dr. Alan Taylor, on the Science Hat Podcast to learn how copper isotope manufacturing and logistics will enable global reach of radiopharmaceuticals and maximise the benefit for patients.

Click on the following link to watch previous episodes of the Science Hat Podcast and learn more about Clarity’s Targeted Copper Theranostic (TCT) platform that uses Cu-64 for imaging and Cu-67 for therapy: https://www.claritypharmaceuticals.co...